CELGCelgene Corporation
CELG
Celgene Corporation12,273
Wealthfront Advisers LLC Acquires 21,704 Shares of Bristol Myers Squibb Company $BMY
Wealthfront Advisers LLC grew its holdings in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 6.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 355,118 shares of the biopharmaceutical company's stock after acquiring an addi...
MarketBeat·5h ago
Erste Group Bank Has Positive Outlook of BMY FY2027 Earnings
Bristol Myers Squibb Company (NYSE:BMY - Free Report) - Analysts at Erste Group Bank increased their FY2027 earnings per share (EPS) estimates for Bristol Myers Squibb in a report released on Monday, April 27th. Erste Group Bank analyst H. Engel now forecasts that the biopharmaceutical company will...
MarketBeat·6h ago
Fagan Associates Inc. Trims Stock Position in Bristol Myers Squibb Company $BMY
Fagan Associates Inc. cut its holdings in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 93.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,452 shares of the biopharmaceutical company's stock after selling 66,048 shares during the...
MarketBeat·9h ago
Bristol Myers Squibb Company $BMY Shares Sold by Skylands Capital LLC
Skylands Capital LLC lowered its stake in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 11.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 142,480 shares of the biopharmaceutical company's stock after selli...
MarketBeat·1d ago
Mitsubishi UFJ Trust & Banking Corp Trims Position in Bristol Myers Squibb Company $BMY
Mitsubishi UFJ Trust & Banking Corp decreased its stake in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 40.1% in the fourth quarter, according to its most recent 13F filing with...
MarketBeat·1d ago
Bristol Myers Squibb Company $BMY Stock Position Reduced by R Squared Ltd
R Squared Ltd cut its stake in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 53.6% during the fourth quarter, according to its most recent disclosure with the SEC. The...
MarketBeat·1d ago
Bristol Myers Squibb Company $BMY Shares Sold by M&T Bank Corp
M&T Bank Corp lowered its position in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 93.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 51,961 shares of the bioph...
MarketBeat·1d ago
Comerica Bank Decreases Stake in Bristol Myers Squibb Company $BMY
Comerica Bank reduced its position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 3.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 637,744 shares of the biopharmaceutical company...
MarketBeat·1d ago
D.A. Davidson & CO. Purchases 28,410 Shares of Bristol Myers Squibb Company $BMY
D.A. Davidson & CO. lifted its holdings in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 10.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 294,929 shares of the biopharmaceutical company's stock after purchasing an additional 28...
MarketBeat·1d ago
Bristol Myers Squibb Company (NYSE:BMY) Given Consensus Recommendation of "Hold" by Brokerages
Shares of Bristol Myers Squibb Company (NYSE:BMY - Get Free Report) have received an average rating of "Hold" from the nineteen research firms that are presently covering the stock, MarketBeat.com...
MarketBeat·1d ago
<
1
2
...
>